These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24045339)

  • 1. IFNL3 mediates interaction between innate immune cells: Implications for hepatitis C virus pathogenesis.
    O'Connor KS; Ahlenstiel G; Suppiah V; Schibeci S; Ong A; Leung R; van der Poorten D; Douglas MW; Weltman MD; Stewart GJ; Liddle C; George J; Booth DR
    Innate Immun; 2014 Aug; 20(6):598-605. PubMed ID: 24045339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum IFN-λ3 Levels Correlate with Serum Hepatitis C Virus RNA Levels in Symptomatic Patients with Acute Hepatitis C.
    Imoto S; Kim SR; Amano K; Iio E; Yoon S; Hirohata S; Yano Y; Ishikawa T; Katsushima S; Komeda T; Fukunaga T; Chung H; Kokuryu H; Horie Y; Hatae T; Fujinami A; Kim SK; Kudo M; Tanaka Y
    Dig Dis; 2017; 35(6):531-540. PubMed ID: 29040985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells in hepatitis C virus infection: key players in the IFNL3-genotype response.
    O'Connor KS; George J; Booth D; Ahlenstiel G
    World J Gastroenterol; 2014 Dec; 20(47):17830-8. PubMed ID: 25548481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infection.
    O'Connor KS; Read SA; Wang M; Schibeci S; Eslam M; Ong A; Weltman MD; Douglas MW; Mazzola A; Craxì A; Petta S; Stewart GJ; Liddle C; George J; Ahlenstiel G; Booth DR
    Genes Immun; 2016 Sep; 17(6):328-34. PubMed ID: 27307212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occult hepatitis C virus infection in hemophilia patients and its correlation with interferon lambda 3 and 4 polymorphisms.
    Nafari AH; Ayadi A; Noormohamadi Z; Sakhaee F; Vaziri F; Siadat SD; Fateh A
    Infect Genet Evol; 2020 Apr; 79():104144. PubMed ID: 31838260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of
    Świątek-Kościelna B; Kałużna E; Strauss E; Nowak J; Bereszyńska I; Gowin E; Wysocki J; Rembowska J; Barcińska D; Mozer-Lisewska I; Januszkiewicz-Lewandowska D
    World J Gastroenterol; 2017 Jun; 23(21):3815-3824. PubMed ID: 28638221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of interferon λ3 gene polymorphisms, rs8099917 and rs12979860, on response to hepatitis B virus vaccination and hepatitis B or C virus infections among hemodialysis patients.
    Grzegorzewska AE; Jodłowska E; Mostowska A; Jagodziński P
    Pol Arch Med Wewn; 2015; 125(12):894-902. PubMed ID: 26658164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favourable IFNL3 genotypes are associated with spontaneous clearance and are differentially distributed in Aboriginals in Canadian HIV-hepatitis C co-infected individuals.
    Moqueet N; Infante-Rivard C; Platt RW; Young J; Cooper C; Hull M; Walmsley S; Klein MB;
    Int J Mol Sci; 2015 Mar; 16(3):6496-512. PubMed ID: 25803108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFNL4 and IFNL3 associated polymorphisms strongly influence the spontaneous IFN-alpha receptor-1 expression in HCV-infected patients.
    Bordi L; Caglioti C; Garbuglia AR; Lapa D; Castilletti C; Taibi C; Capobianchi MR; Lalle E
    PLoS One; 2015; 10(2):e0117397. PubMed ID: 25675103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection.
    Eslam M; Leung R; Romero-Gomez M; Mangia A; Irving WL; Sheridan D; Spengler U; Mollison L; Cheng W; Bugianesi E; McLeod D; Zaitoun AM; Attino V; Goeltz D; Nattermann J; Douglas M; Booth DR; George J; Ahlenstiel G
    J Hepatol; 2014 Aug; 61(2):235-41. PubMed ID: 24768758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered effector functions of NK cells in chronic hepatitis C are associated with IFNL3 polymorphism.
    Rogalska-Taranta M; Markova AA; Taranta A; Lunemann S; Schlaphoff V; Flisiak R; Manns MP; Cornberg M; Kraft AR; Wedemeyer H
    J Leukoc Biol; 2015 Aug; 98(2):283-94. PubMed ID: 26034208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A polymorphism in interferon L3 is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis C virus infection.
    Chang KC; Tseng PL; Wu YY; Hung HC; Huang CM; Lu SN; Wang JH; Lee CM; Chen CH; Tsai MC; Yen YH; Lin MT; Wu CK; Huang CC; Chen HH; Hu TH
    Clin Gastroenterol Hepatol; 2015 May; 13(5):1017-24. PubMed ID: 25460552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient virus assembly, but not infectivity, determines the magnitude of hepatitis C virus-induced interferon alpha responses of plasmacytoid dendritic cells.
    Grabski E; Wappler I; Pfaender S; Steinmann E; Haid S; Dzionek A; Pietschmann T; Kalinke U
    J Virol; 2015 Mar; 89(6):3200-8. PubMed ID: 25552725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate and adaptive genetic pathways in HCV infection.
    Buchanan R; Hydes T; Khakoo SI
    Tissue Antigens; 2015 Apr; 85(4):231-40. PubMed ID: 25708172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients.
    Murakawa M; Asahina Y; Kawai-Kitahata F; Nakagawa M; Nitta S; Otani S; Nagata H; Kaneko S; Asano Y; Tsunoda T; Miyoshi M; Itsui Y; Azuma S; Kakinuma S; Tanaka Y; Iijima S; Tsuchiya K; Izumi N; Tohda S; Watanabe M
    J Med Virol; 2017 Jul; 89(7):1241-1247. PubMed ID: 28036111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-λ3 polymorphisms in pegylated-interferon-α plus ribavirin therapy for genotype-2 chronic hepatitis C.
    Ishiguro H; Abe H; Seki N; Sugita T; Aida Y; Itagaki M; Sutoh S; Shimada N; Furihata T; Tsubota A; Aizawa Y
    World J Gastroenterol; 2015 Apr; 21(13):3904-11. PubMed ID: 25852275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFNL3 genotype is associated with differential induction of IFNL3 in primary human hepatocytes.
    Kurbanov F; Kim Y; Latanich R; Chaudhari P; El-Diwany R; Knabel M; Kandathil AJ; Cameron A; Cox A; Jang YY; Thomas DL; Balagopal A
    Antivir Ther; 2015; 20(8):805-14. PubMed ID: 26109548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFNL3 (IL28B) and IFNL4 polymorphisms are associated with treatment response in Thai patients infected with HCV genotype 1, but not with genotypes 3 and 6.
    Akkarathamrongsin S; Thong VD; Payungporn S; Poovorawan K; Prapunwattana P; Poovorawan Y; Tangkijvanich P
    J Med Virol; 2014 Sep; 86(9):1482-90. PubMed ID: 24782280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged activation of innate antiviral gene signature after childbirth is determined by IFNL3 genotype.
    Price AA; Tedesco D; Prasad MR; Workowski KA; Walker CM; Suthar MS; Honegger JR; Grakoui A
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):10678-83. PubMed ID: 27601663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphism of the IL28B gene (rs8099917, rs12979860) and virological response of Pakistani hepatitis C virus genotype 3 patients to pegylated interferon therapy.
    Aziz H; Raza A; Ali K; Khattak JZ; Irfan J; Gill ML
    Int J Infect Dis; 2015 Jan; 30():91-7. PubMed ID: 25462177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.